Release Date: 08/02/11 12:07 Summary: Traxys Agency Agreement Price Sensitive: Yes Download Document 378.21KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%